View in EDS PDF Full Text

Combination of two different dopamine agonists in the management of Parkinson's disease.

Saved in:
Bibliographic Details
Title: Combination of two different dopamine agonists in the management of Parkinson's disease.
Authors: Stocchi, F., Berardelli, A., Vacca, L., Thomas, A., De Pandis, M.F., Modugno, N., Valente, M., Ruggieri, S.
Source: Neurological Sciences. Sep2002 Supplement 2, Vol. 23, pS115. 2p.
Subjects: Parkinson's disease, Dopamine agonists
Abstract: An alternative approach to the symptomatic treatment of parkinsonian patients with and without motor fluctuations is to use dual dopamine agonists. The aim of this study was to investigate the symptomatic effect of administrating a second dopamine agonist to parkinsonian patients already assuming pramipexole or ropinirole. As the second dopamine agonist we chose cabergoline, a drug with a long half life, whose pharmacological profile differs from that of the newer non-ergot-derived dopamine-receptor agonists. In this pilot study we enrolled 27 patients: 21 patients had motor fluctuations and were receiving levodopa plus a dopamine agonist, and 6 patients without motor fluctuations were receiving a dopamine agonist without levodopa. This open study shows that dual dopamine-agonist therapy (cabergoline plus pramipexole or ropinirole) may be used in the symptomatic treatment of patients with Parkinson's disease receiving therapy with or without levodopa. [ABSTRACT FROM AUTHOR]
Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 8907964
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combination of two different dopamine agonists in the management of Parkinson's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Stocchi%2C+F%2E%22">Stocchi, F.</searchLink><br /><searchLink fieldCode="AR" term="%22Berardelli%2C+A%2E%22">Berardelli, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Vacca%2C+L%2E%22">Vacca, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Thomas%2C+A%2E%22">Thomas, A.</searchLink><br /><searchLink fieldCode="AR" term="%22De+Pandis%2C+M%2EF%2E%22">De Pandis, M.F.</searchLink><br /><searchLink fieldCode="AR" term="%22Modugno%2C+N%2E%22">Modugno, N.</searchLink><br /><searchLink fieldCode="AR" term="%22Valente%2C+M%2E%22">Valente, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Ruggieri%2C+S%2E%22">Ruggieri, S.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Sep2002 Supplement 2, Vol. 23, pS115. 2p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Parkinson's+disease%22">Parkinson's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Dopamine+agonists%22">Dopamine agonists</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: An alternative approach to the symptomatic treatment of parkinsonian patients with and without motor fluctuations is to use dual dopamine agonists. The aim of this study was to investigate the symptomatic effect of administrating a second dopamine agonist to parkinsonian patients already assuming pramipexole or ropinirole. As the second dopamine agonist we chose cabergoline, a drug with a long half life, whose pharmacological profile differs from that of the newer non-ergot-derived dopamine-receptor agonists. In this pilot study we enrolled 27 patients: 21 patients had motor fluctuations and were receiving levodopa plus a dopamine agonist, and 6 patients without motor fluctuations were receiving a dopamine agonist without levodopa. This open study shows that dual dopamine-agonist therapy (cabergoline plus pramipexole or ropinirole) may be used in the symptomatic treatment of patients with Parkinson's disease receiving therapy with or without levodopa. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=8907964
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s100720200096
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S115
    Subjects:
      – SubjectFull: Parkinson's disease
        Type: general
      – SubjectFull: Dopamine agonists
        Type: general
    Titles:
      – TitleFull: Combination of two different dopamine agonists in the management of Parkinson's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stocchi, F.
      – PersonEntity:
          Name:
            NameFull: Berardelli, A.
      – PersonEntity:
          Name:
            NameFull: Vacca, L.
      – PersonEntity:
          Name:
            NameFull: Thomas, A.
      – PersonEntity:
          Name:
            NameFull: De Pandis, M.F.
      – PersonEntity:
          Name:
            NameFull: Modugno, N.
      – PersonEntity:
          Name:
            NameFull: Valente, M.
      – PersonEntity:
          Name:
            NameFull: Ruggieri, S.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: Sep2002 Supplement 2
              Type: published
              Y: 2002
          Identifiers:
            – Type: issn-print
              Value: 15901874
          Numbering:
            – Type: volume
              Value: 23
          Titles:
            – TitleFull: Neurological Sciences
              Type: main
ResultId 1